Anterior uveitis as a complication of treatment with high dose cytosine-arabinoside

American Journal of Hematology

Volumn 76, Issue 3, 2004, Pages 304-306

  Planer, David ^a   Cukierman, Tali ^a   Liebster, Diana ^a   Ilsar, Michael ^a   Chajek Shaul, Tova ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Anterior uveitis; Complication; High dose cytosine arabinoside

Indexed keywords

ANALGESIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; METHOTREXATE; SODIUM CHLORIDE; STEROID; VINCRISTINE;

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; CLINICAL PROTOCOL; CONJUNCTIVITIS; DISEASE COURSE; DRUG MEGADOSE; EYE PAIN; FEMALE; HUMAN; IRIDOCYCLITIS; PATIENT COMPLIANCE; PHOTOPHOBIA; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; BREAST NEOPLASMS; CYTARABINE; FEMALE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; UVEITIS, ANTERIOR;

EID: 3042555362     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20082     Document Type: Article

References (10)

1. Thomas DA, Cortes J, O'Brien S, et al. Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia. J Clin Oncol 1999;17(8):2461-2470.
2. Rothova A, Ooijman F, Kerkhoff F, Van Der Lelij A, Lokhorst HM. Uveitis masquerade syndromes. Ophthalmology 2001;108(2): 386-399.
3. Grant S, Ara-C: cellular and molecular pharmacology. Adv Cancer Res 1998;72:197-233.
4. Herzig RH, Wolff SN, Lazarus HM, Phillips GL, Karanes C, Herzig GP. High-dose cytosine arabinoside therapy for refractory leukemia. Blood 1983;62(2):361-369.
5. Graves T, Hooks MA. Drug-induced toxicities associated with high-dose cytosine arabinoside infusions. Pharmacotherapy 1989;9(1): 23-28.
6. Higa GM, Gockerman JP, Hunt AL, Jones MR, Horne BJ. The use of prophylactic eye drops during high-dose cytosine arabinoside therapy. Cancer 1991;68(8):1691-1693.
7. Ritch PS, Hansen RM, Heuer DK. Ocular toxicity from high-dose cytosine arabinoside. Cancer 1983;51(3):430-432.
8. Hoffman DL, Howard JR Jr, Sarma R, Riggs JE. Encephalopathy, myelopathy, optic neuropathy, and anosmia associated with intravenous cytosine arabinoside. Clin Neuropharmacol 1993;16(3):258-262.
9. Schwartz J, Alster Y, Ben-Tal O, Lowenstein A. Visual loss following high-dose cytosine arabinoside (ARA-C). Eur J Haematol 2000;64(3):208-209.
10. Fraunfelder FW, Rosenbaum JT. Drug-induced uveitis. Incidence, prevention and treatment. Drug Saf 1997;17(3):197-207.